Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Quanterix Corp Perfil



Código da empresaQTRX

Nome da EmpresaQuanterix Corp

Data de listagemDec 07, 2017

CEOToloue (Masoud)

Número de funcionários471

Tipo de títulosOrdinary Share

Fim do ano fiscalDec 07

Endereço900 Middlesex Turnpike

CidadeBILLERICA

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal01821

Telefone16173019400

Sitehttps://www.quanterix.com/

Código da empresaQTRX

Data de listagemDec 07, 2017

CEOToloue (Masoud)

Executivos da empresa Quanterix Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

355.02K

+20.48%

Mr. William P. (Bill) Donnelly

Non-Executive Chairman of the Board

162.40K

+1.73%

Mr. William P. (Bill) Donnelly

Non-Executive Chairman of the Board

162.40K

+1.73%

Mr. William P. (Bill) Donnelly

Non-Executive Chairman of the Board

162.40K

+1.73%

Mr. Michael Francis Miller

Chief Technology and Products Officer

38.45K

+2.84%

Mr. Michael Francis Miller

Chief Technology and Products Officer

38.45K

+2.84%

Mr. Michael Francis Miller

Chief Technology and Products Officer

38.45K

+2.84%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

34.95K

+3.68%

Ms. Karen A. Flynn

Independent Director

33.84K

-47.10%

Ms. Karen A. Flynn

Independent Director

33.84K

-47.10%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

355.02K

+20.48%

Mr. William P. (Bill) Donnelly

Non-Executive Chairman of the Board

162.40K

+1.73%

Mr. William P. (Bill) Donnelly

Non-Executive Chairman of the Board

162.40K

+1.73%

Mr. William P. (Bill) Donnelly

Non-Executive Chairman of the Board

162.40K

+1.73%

Mr. Michael Francis Miller

Chief Technology and Products Officer

38.45K

+2.84%

Mr. Michael Francis Miller

Chief Technology and Products Officer

38.45K

+2.84%

Perguntas frequentes

Quem são os cinco principais acionistas de Quanterix Corp?



Os cinco principais acionistas de Quanterix Corp são: Dr. Masoud Toloue, Ph.D.

Quantas instituições possuem ações da Quanterix Corp (QTRX)?



Em 2026Q1, 371 instituições possuíam ações da Quanterix Corp, com valor de mercado aproximado de 42.63M, representando 90.49% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -4982326.00.

Qual é a maior fonte de receita da Quanterix Corp?



Em 2026Q1, o segmento de negócios Product revenue gerou a maior receita para Quanterix Corp, totalizando 23.48M e representando 71.34% da receita total.